Australia, Authorisations, Cartels, Competition & antitrust Authorisation no cure to cartel risks posed by pharmaceutical patent settlement agreements 29 August 2022 By Lisa Huett Read on
Australia, Cartels, Enforcement, Reform Patently uncertain: developments in pay-for-delay agreements in Australia 11 June 2020 By Christopher Kew Read on
